4//SEC Filing
Meeker David P 4
Accession 0000950170-24-101926
CIK 0001563880other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:55 PM ET
Size
8.6 KB
Accession
0000950170-24-101926
Insider Transaction Report
Form 4
Meeker David P
Director
Transactions
- Exercise/Conversion
Common Stock
2024-08-27$1.43/sh+4,555$6,514→ 357,044 total - Sale
Common Stock
2024-08-27$2.93/sh−4,555$13,353→ 352,489 total - Exercise/Conversion
Stock Option (right to buy)
2024-08-27−4,555→ 0 totalExercise: $1.43Exp: 2024-11-24→ Common Stock (4,555 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.9100 to $2.9500 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]This option was granted on November 25, 2014. The 4,555 shares of common stock underlying the option vested as to 25% of the shares on November 25, 2015 and vested as to the remaining 75% of the shares in equal quarterly installments thereafter through November 25, 2018.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001385155
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:55 PM ET
- Size
- 8.6 KB